Long Focus Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Long Focus Capital Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54,938	Closed	-$1.3M	–	116
2023 Q4	$1.3M	Hold	54,938	–	–	0.17%	82
2023 Q3	$1.11M	Hold	54,938	–	–	0.16%	85
2023 Q2	$1.43M	Sell	54,938 -15,810	-22%	-$452K	0.22%	78
2023 Q1	$1.47M	Hold	70,748	–	–	0.24%	79
2022 Q4	$1.44M	Buy	+70,748	New	+$1.33M	0.24%	71
2022 Q3	–	Sell	-49,000	Closed	-$1.41M	–	122
2022 Q2	$1.29M	Buy	49,000 +27,490	+128%	+$1.22M	0.26%	69
2022 Q1	$1.72M	Buy	21,510 +14,500	+207%	+$1.79M	0.37%	64
2021 Q4	$1.43M	Buy	+7,010	New	+$1.75M	0.39%	62

Other funds holding VINC

Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return